Company intelligence / Profile preview

SteadMed Medical

Fort Worth, Texas, United States

Ownership: Private
Employees: ~41
Development stage: Other

Overview

SteadMed Medical was a U.S.-based company specializing in advanced wound care and skin care products, operating commercially until its acquisition by URGO Medical in 2018. Its portfolio focused on devices and non-pharmacological solutions for wound bed preparation, cleansing, and management of severe and chronic wounds. Clinical data is not publicly available beyond standard device approvals.

Therapeutic areas: EndocrinologyCardiovascularOtherDermatology
Modalities: DeviceNon-pharmacological therapy
Industry: Consumable Medical Devices

Partnerships

Hollister (for Restore and TRIACT technology)ACell (previously for XPansion product)

Beyond the preview

Go deeper on SteadMed Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SteadMed Medical.

Explore the full profile